Senexon-s Tablet, Film Coated
Product Images NDC 0615-8331

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Senexon-s (NDC 0615-8331). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Senexon S Docusate Sodium Sennosides Tabs 50 mg 8 1)

Principal Display Panel (Senexon S Docusate Sodium Sennosides Tabs 50 mg 8  1)
This seems to be a description of a medicine called Senexon-S (Docusate Sodium/Sennosides) made by Pharbest for Rugby, containing 50 mg/8.6 mg of Docusate sodium and Sennosides. The tablets have a softening effect and are intended for institutional use. The package contains general information, dosage information, and warnings, with a warning to visit a specific website for more information. Some location information and other details are also included.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.